Mr. Minh Tran is a seasoned biopharmaceutical leader with over 28 years of technical and commercial experience spanning process development, technology transfer, manufacturing operations, and executive management. He currently leads the Global Process Automation, PAT, and Data Analytics commercial business at Merck KGaA, driving innovation, digital transformation, and strategic growth in the industry.

Before joining Merck in Singapore, Mr. Tran served as Chief Operating Officer at Stelis Biopharma, where he oversaw all aspects of commercial manufacturing operations and CDMO activities. He previously held key leadership roles, including Head of Large Investment Projects for APAC at EMD Millipore, and contributed to major biopharma organizations such as Amgen, ICOS Corporation, Novo Nordisk, and Immunex Corporation in the U.S.

Mr. Tran holds a Bachelor of Science in Microbiology from the University of Washington, Seattle. His expertise and leadership continue to shape the future of biopharmaceutical innovation and manufacturing excellence.

Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. That’s where we come in. We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services and digital offerings help create solutions for people globally and a sustainable future for generations to come. Merck is a global science and technology company with around 60,000 employees in more than 66 countries.